Pharmaceuticals

U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer

-  Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status -  The application is being reviewed under the FDA's Real-Time Oncology Review pilot pr...

2020-02-24 22:00 122

Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus

HANOI, Vietnam, Feb. 21, 2020 /PRNewswire/ -- 3 units funded by Vingroup Innovation Foundation (VINIF) include The Company for Vaccine and Biological Production No.1 (Vabiotech), Pasteur Institute inHo Chi Minh City and Institute of Preventive Medicine and Public Health.

2020-02-21 10:09 1212

Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region

HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...

2020-02-20 18:59 4424

NeuroVive Pharmaceutical AB Year End Report January - December 2019

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333            * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study            * NeuroVive compl...

2020-02-19 16:08 4471

WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that WuXi Vaccines, its joint venture with Shanghai ...

2020-02-18 18:42 193

Sihuan Pharmaceutical: Production Approval Granted For Rivastigmine Hydrogen Tartrate Capsule, The First Drug Passing Consistency Evaluation And Levetiracetam Tablet And The First Registration Approval Granted For Midazolam Oromucosal Solution

HONG KONG, Feb. 18, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that rivastigmine hydrogen tartrate capsule and levetiracetam tablet developed by the Group...

2020-02-18 18:07 5276

Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA

HANGZHOU, China and SHAOXING, China, Feb. 18, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the application for in-house developed Category 1 Drug ASC41 for clinical trials of NASH indication has been accepted byChina's National Medical Products Administration (NMPA)...

2020-02-18 08:00 880

A New Expert Consensus Publication Provides Practical Guidance on the Use of Omega-3 Fatty Acids in Parenteral Nutrition

BAD HOMBURG, Germany, Feb. 17, 2020 /PRNewswire/ -- Fresenius Kabi, a global leader in clinical nutrition, announces that the Journal of Parenteral and Enteral Nutrition (JPEN) has recently published "Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice".[1] The publicati...

2020-02-17 17:00 1295

Eirgenix Receives Approval from Japan's PMDA

TAIPEI, Feb. 14, 2020 /PRNewswire/ -- EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanese pharmaceutical company and has since fulfilled all the regulatory requirements necessary to complete the manufacturing site transfer. The ...

2020-02-14 15:14 723

Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases

HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the progress achieved by the Group in the research and development of drugs for treati...

2020-02-14 10:35 5755

Sirtex Medical announces collaboration with MIM Software Inc.

Partnership advances innovation and increases precision of liver-directed oncology therapies for patients WOBURN, Massachusetts, Feb. 12, 2020 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced a collaboration with MIM Software Inc., a lead...

2020-02-12 22:00 616

Sihuan Pharmaceutical and Hetero Labs Limited Reached A Framework Cooperation Agreement in Pharmaceutical Manufacturing Area

HONG KONG, Feb. 12, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the Group and Hetero Labs Limited ("Hetero"), a company registered under the laws ofI...

2020-02-12 05:00 5665

IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs

MENLO PARK, California, Feb. 12, 2020 /PRNewswire/ -- IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in im...

2020-02-12 03:25 370

Major Tobacco Manufacturer Selects ArisGlobal's LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes

A multinational tobacco products manufacturing company recently selected ArisGlobal's LifeSphere® MultiVigilance 10 for their global safety vigilance needs MIAMI, Feb. 11, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functio...

2020-02-11 20:30 505

Vakrangee to Revolutionize Rural Healthcare in India: Plans to Rollout Telemedicine Services From vHealth by AETNA (a CVS Health Company)

MUMBAI, India, Feb. 11, 2020 /PRNewswire/ -- Vakrangee Limited (VL) announces alliance with vHealth by Aetna which is fully owned subsidiary of Aetna Inc, a CVS Health Company (Fortune 8 enterprise), one of the world's leading health services providers, to offer a combination of Telemedicine serv...

2020-02-11 16:42 1153

Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020

PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced  the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...

2020-02-10 21:42 4158

Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)

- RRP is a rare, potentially fatal orphan disease caused by Human Papillomavirus (HPV) 6 and 11 - Inovio's DNA medicine pipeline includes 15 clinical programs focused on HPV-associated diseases, cancer, and infectious diseases, including the novel coronavirus (2019-nCoV) PLYMOUTH MEETING, Penns...

2020-02-10 19:00 905

GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours

NANJING, China, Feb. 10, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District, Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CA...

2020-02-10 10:49 432

RhoVac Announces Appointment of Professor Anne J. Ridley to its Scientific Advisory Board

STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6 th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition ofAnne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, ...

2020-02-06 20:22 561

Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer

MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study  by scientists from India, USA, and UK has presented clinical evidence for an innovative test that can detect clusters of cancer cells in the blood of asymptomatic individuals as a...

2020-02-06 08:00 613
12345 ... 66